Why is this important?
Appropriate care should see that patients receive the right type and amount of care, in the right place, at the right time. The care offered should also be based on the best available evidence.
The Commission is now operating in accordance with the Caretaker ConventionsExternal link pending the outcome of the 2025 federal election.
Appropriate care should see that patients receive the right type and amount of care, in the right place, at the right time. The care offered should also be based on the best available evidence.
The Commission is seeking feedback on potential changes to the accreditation cycle and assessment of general practices.
On the Radar Issue 686 is now available.
The Commission is upgrading the Australian Register of Clinical Registries (the Register) as part of the National Strategy for Clinical Quality Registries and Virtual Registries 2020 – 2030.
This issue includes items on the OECD’s Patient-Reported Indicator Survey (PaRIS) report, the latest antimicrobial surveillance report, telemedicine, virtual care, heavy menstrual bleeding, prevention, and more. Also covered are the latest from BMJ Quality &Safety, Australian Journal of Primary Health, Australian Prescriber, Journal of Patient Safety, Pediatric Quality & Safety, Journal for Healthcare Quality and the UK’s NICE and Healthcare Excellence Canada.
A webpage that outlines infection prevention and control strategies for managing Candida auris in Australian health service organisations.
On the Radar Issue 684 is now available.
On the Radar Issue 685 is now available.
Read how a multidisciplinary team consisting of infectious disease specialists, pharmacists, nurses and implementation scientists improved vancomycin prescribing in Queensland. Co-design with clinicians involved in prescribing, dispensing and administering vancomycin was key to success.
View more case studies that showcase best practice in the review of clinical variation.
Do you have a case study to contribute?
We will work with you to write the case study. Please contact us on Atlas@safetyandquality.gov.au
Complexities involving management and monitoring of vancomycin lead to medication errors including inaccurate dosing, inappropriate timing of sample collection for therapeutic drug monitoring and inappropriate dose adjustments. Early optimisation of vancomycin management reduces mortality, renal injury and other adverse effects.
Despite availability of guidelines and training, vancomycin management remained suboptimal in four teaching hospitals in a large Queensland Hospital and Health Service (HHS). The uptake of strategies to optimise the management of vancomycin therapy into routine care was identified as an area for improvement.
The project was conducted in four phases:
Baseline audits revealed that only a small proportion of vancomycin doses were appropriately prescribed and monitored. Key findings included:
Focus groups consisting of nurses, pharmacists and doctors were conducted to review the design of the intervention materials, assess their relevance and explore key themes to optimise the management of vancomycin.
Findings from the focus groups identified key reasons for inappropriate management of vancomycin. These included:
The following feedback from stakeholders informed the development of an intervention package:
A multi-faceted intervention package was developed for nurses, pharmacists and medical officers which included e-Learning modules, guidelines, lanyards and fact sheets. On-site champions at each facility, supported by the Steering Committee, facilitated the uptake of the intervention package.
The overall appropriateness of vancomycin prescribing and monitoring improved to 80% for facilities within the four HHSs.
In one facility, the audits showed improved adherence to dosing recommendations in line with vancomycin guidelines:
All patients monitored through therapeutic drug monitoring at this facility received dosing recommendations based on the guidelines or advice from the QLD Statewide Antimicrobial Stewardship Service.
Read about the project here: https://doi.org/10.1016/j.sapharm.2024.01.012
Development and implementation of an intervention package that included: